Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry

OBJECTIVE: The purpose of this study was to evaluate maintenance of remission/low disease activity (LDA) in patients with rheumatoid arthritis (RA) who achieved remission/LDA with etanercept (ETN) plus a conventional synthetic disease‐modifying antirheumatic drug (csDMARD) and to compare patients wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Pappas, Dimitrios A., Shan, Ying, Lesperance, Tamara, Kricorian, Greg, Karis, Elaine, Rebello, Sabrina, Hua, Winnie, Accortt, Neil A., Stryker, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571397/
https://www.ncbi.nlm.nih.gov/pubmed/32990361
http://dx.doi.org/10.1002/acr2.11168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571397/
https://www.ncbi.nlm.nih.gov/pubmed/32990361
http://dx.doi.org/10.1002/acr2.11168

Ejemplares similares